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Ideas and words come in and out of fashion just like
clothing, and in too many cases their real impact on the
world, when viewed from a historical perspective, is not
significantly greater than these other "fashions". But
sometimes, seemingly by chance, the words and ideas
that are in fashion match the real needs and opportunities
of their time. At these times, progress far beyond the
normal slope of forward movement can be achieved by
forging real solutions from the tinsel of well-supported,
fashionable ideas. I believe such a time is at hand for
agricultural research. Four words or phrases currently
very much in style are biotechnology, economic development,
new partnerships and excellence. These mirror the unique
opportunity that the agricultural research community has
to address the economic chaos and depression that has
seized American agriculture. Today I would like to ad-
dress the real substance of these terms and the special way
in which their meaning and potential for agriculture and
agricultural research expand when they are viewed in the
context of each other.
Biotechnology is often defined as the use of biological
systems to produce substances and products too complex
and expensive to make by other traditional chemical
means. Biotechnology, as farming, is the husbandry of
life forms to produce products. The concept of using the
complex biological systems and mechanisms of nature's
living organisms to produce products is as old as civiliza-
tion itself. It is also very new and offers totally new ways
of altering and improving these age-old systems. Both
the new opportunities offered by biotechnology and its
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fundamental identity with agriculture suggest an enor-
mous positive impact upon agriculture by this "fashion-
able" subject.
Before discussing the role of biotechnology in agricul-
ture, it is useful to more closely examine the technology
and the depth and breadth of its application in all areas
of production and industry. The new biotechnology had
its beginnings a little over a decade ago in research find-
ings emanating from the study of molecular genetics and
microbiology. The discovery of sequence-specific DNA
cleavage enzymes known as restriction endonucleases
and the perfection of other in vitro enzymatic means for
the ligation or reconstruction of DNA molecules from
isolated "restricted fragments" made possible specific,
directed recombination between virtually any genetic
information. Application of recombinant genetics first oc-
curred in microbial systems where the existence of
extrachromosomal genetic elements called plasmids,
able to enter freely a variety of microorganisms and im-
part their genetic influence, allowed an easy means of
transferring genes into these organisms. A range of iso-
lated or cloned genes were introduced into bacteria and
other microorganisms, generating recombinant micro-
organisms able to produce a variety of gene products.
Some of the products produced by recombinant micro-
organisms are today commercially available in the form of
prescription pharmaceuticals. Human insulin, marketed
by Eli Lilly for the treatment of diabetes, and human
growth hormone, marketed by Genentech for the treat-
ment of pituitary dwarfism, provide well-known exam-
ples of the first pharmaceutical products approved by the
Food and Drug Administration. Other important new
agents for the treatment of cancer, such as interferon,
interleukin-2, and other lymphokines, are examples of
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the first harvest of microbial biotechnology. But because
of the initial emphasis on pharmaceuticals — high profit
margin products developed by an industry with a huge
research budget able to support the initial technology
development — many outside observers still see bio-
technology as simply an exciting new means to produce
new protein pharmaceuticals. Nothing could be further
from reality.
A combination of the need for molecules far too com-
plex to be produced by chemical synthesis, the im-
pending decline in both the chemical feedstocks and fuels
needed to drive the chemical industry, and increasing
concern about the pollutants and by-products of produc-
tion chemistry have prompted a dramatic turn from a
basic chemitechnology to biotechnology. Already tradi-
tional biotechnology is used in such diverse arenas as
minerals extraction in mining operations, for tertiary oil
recovery, to produce more than 50 different complex
chemicals, in the fermentation industry and in food pro-
cessing, and in the pharmaceutical and vaccine industry.
Methods and systems using industrial enzymes, produced
by recombinant organisms, to catalyze complex multi-
step reactions for the synthesis of existing and new
molecular products are at the pilot stage in many
corporations throughout the world. Clearly, the age of
biotechnology is upon us. But we are viewing only the
very edge of change. In spite of the dramatic initiatives
in the pharmaceutical and chemical industry, expert
analysts, including the Office of Technology Assessment
of the U.S. Congress, predict that the largest impact
and increased proceeds from biotechnology will be in
agriculture. Increased profits to the agricultural sector in
excess of $ 100 billion per year are predicted within a
decade as the direct result of biotechnological advances.
Although I agree with the potential of these predictions,
I am not quite so sure of their realization within this time
period. The agenda for incorporating this new tech-
nology into the fabric of American agriculture is large
and complex and defines the challenges facing our
colleagues throughout the agricultural research, economic
development, and extension communities. They are
probably more exciting and more demanding than any of
the challenges previously faced by these groups.
Life forms on earth may be divided among three gen-
eral groups: microbes, plants, and animals. Since almost
all systems presently using the new biotechnology are
based on microbial systems and because broad-reaching,
new methods of introducing cloned genes into plants and
animals have been developed, it is clear that much of the
future development of biotechnology will be in the
realms of plants and animals. The use of plants and
animals to produce products is agriculture. This is pre-
cisely the reason such a major impact by biotechnology
on agriculture is predicted. Whereas chemical, pharma-
ceutical, and fermentation industries may move to pro-
duction through microbial biotechnology, it is American
agriculture and the American farmer, through their link
to us in the agricultural research community, who will be
called upon to become the plant and animal bio-
technology industry of the future. What will this industry
be like? What kinds and range of products will it pro-
duce? Our best guess as to the answers to these questions
lies in the present laboratory successes in the fields of
plant and animal recombinant genetics and bio-
technology.
How may this biotechnology of animal and plant re-
combinant genetics affect agriculture and the American
farmer? From my vantage point, I see two general areas
of effect: 1) improvement in the production traits of
existing plant and animal farm products by increasing
production efficiency and lowering production costs
to increase profits to a more reasonable level, and 2) pro-
viding totally new, high profit margin, non-food agri-
cultural products. Clearly, the agenda for incorporation
of biotechnology into production agriculture must ad-
dress the first of these before moving to the second.
Several major changes in both production traits and
the basic composition of animal and plant food products
must be the first goal for the application of agricultural
biotechnology by the agricultural research community. A
decade ago many plant and animal geneticists, viewing
the field of genetics from the point of view of population
genetics or plant and animal breeding, believed that such
a large number of specific genes contributed to the major
production traits that genetic engineering approaches to
animal and plant improvement, which allow transfer of
only a few selected genes, could not be used effectively to
improve the production efficiency of farm products.
With an increased understanding of recombinant genetic
techniques and an acceptance of their place in agricultural
research, a new mode of genetic analysis and thinking has
come to the fore. This analysis focuses upon the rate-
determining steps in the complex biological processes
that control the production traits of farm products.
Examples of these traits are growth rates, growth
efficiencies, reproduction effectiveness, and disease
resistance characteristics.
This new approach within the agricultural research
community has provided enormous impetus for the
application of biotechnology in agriculture, and has pro-
vided specific targets for single-gene engineering.
Examples of specific genes that regulate complex, multi-
gene processes of crucial importance to animal agricul-
tural production systems are the growth hormone gene
in growth rate, feed efficiency, leanness and milk pro-
duction; the baroola gene in reproduction rates; and spe-
cific lymphokine genes and histocompatibility genes in
disease resistance. In plants, single genes have been
identified that enhance the efficiency of nitrogen fixation
in nitrogen-fixing plants. A small gene family has also
been found that may allow plants that are not presently
able to fix nitrogen to participate with nitrogen-fixing
bacteria in a symbiosis. Plant molecular biologists have
also isolated several bacterial genes that impart herbicide
resistance to plants, potentially allowing better weed
control in specific crop plant species. Because of the
enormous wealth of genetic information available to the
animal scientist from the huge national research effort in
human health, more progress is being made in animal
biotechnology at present, but the large recent emphasis
on plant molecular biology is closing this gap.
Two specific genes, the animal growth hormone gene
and the bacterial glyphasate resistance gene for plant
herbicide resistance, which have been cloned and trans-
ferred, provide good examples of the direct application of
genetic engineering to crop and livestock agriculture.
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Experimental animals harboring the expressing growth
hormone gene grow over 100% faster than control ani-
mals, are 30% more feed-efficient, and have far less body
fat. Clearly, such traits conferred by a single genetic
construction could dramatically improve the production
characteristics in meat animals. This same gene also con-
fers increases of up to 40% in milk production in lac-
tating dairy cattle. Growth hormone, delivered by some
means, will definitely have a major impact upon dairy
and red meat production in the very near future. One of
the major questions is the means by which this valuable
gene product will be delivered to the farm livestock popu-
lation. Several possibilities are presently under study.
Since this first production-enhancing btotech agent may
serve as the bellwether for future systems, it is impor-
tant to look carefully at the alternatives available and the
way in which each would affect agriculture as we now
know it.
The protein hormone gene product of the growth hor-
mone gene is being produced presently by several com-
mercial groups through the use of a fermentation process
employing growth hormone gene recombinant bacteria.
When this protein hormone is administered to young,
growing animals, substantial increases in growth rates
and feed efficiencies are observed. These production im-
provements are far less, however, than those shown by
transgenic animals that contain the expressing gene. Ad-
ministration of this prepared hormone to lactating dairy
cattle does show the full effects of milk production,
boosting production 20 to 40%.
The advantages of this new production-enhancing
agri-pharmaceutical to the farmer are obvious: increased
product, improved efficiency, and a more effective and
residue-free replacement for the anabolic steroids that are
being maligned by consumer groups. But these advan-
tages have a price. The cost of production and especially
of purification of recombinant proteins from toxic bacte-
rial suspensions is costly. A substantial portion of any
increased profits to farmers will go toward paying these
manufacturing costs as well as the marketing and research
costs for the product. The companies producing these
agents will also realize a profit margin substantially
larger than the farmer ever sees on his products. Also, the
costs to the farmer will not only be in dollars, but also in
increased labor, since regular administration by injection
or implantation will be required.
All of this suggests that a better mode of use of the
growth hormone system may be through the permanent
genetic alteration of farm livestock using animals that
are transgenic for the expressing growth hormone gene,
like the experimental animals described earlier. However,
this system, along with its obvious advantages in effec-
tiveness, cost, and profit share to the farmer, also has
several drawbacks. Any change in the permanent genetic
makeup of a living organism must be compatible with all
aspects of the life cycle of the organism. While genetic
engineering, which increases the level and the duration of
growth hormone production within an animal, clearly
and dramatically increases growth rate and feed effi-
ciency, it also has some negative side effects on female
reproductive performance. This should be of no great
surprise to animal breeders since it has been known for a
long time that an inverse relationship exists between
prolonged, enhanced, growth, and attainment of sexual
maturity. Although present experimental results suggest
that transgenic animals with significantly enhanced
growth rates and acceptable reproductive performance
may be produced, it must be recognized that for per-
manently transgenic animals it will be impossible to
maximize fully a single production trait by genetic engi-
neering. Rather, a balance between all required traits
must be achieved. This is a clear disadvantage compared
to direct protein growth hormone administration for in-
creased meat production, since by using direct protein
administration, only animals destined for slaughter will
be treated, and the effects on reproduction are of no
concern. In dairy cattle, the relative advantage may not
be quite so definite since some concern has been regis-
tered regarding effects on reproductive performance
owing to long-term growth hormone administration.
Delivery to the farmer is a second major practical disad-
vantage to the germline transgenic animal approach to
production increases through the growth hormone sys-
tem. Even if the most desired transgenic livestock could
be produced by the agricultural research community, any
reasonable estimate of the time necessary to reproduce
and disseminate the animals to America's farmers and
ranchers would suggest a time lag of a decade or more.
An alternative to both direct protein hormone delivery
and the germline transgenic animal approach may be
possible. Recent research in several molecular biology
laboratories and at the Edison Animal Biotechnology
Center in Ohio suggests that methods similar, but not
identical, to human gene therapy, where specific genes
may be introduced into populations of somatic cells in a
young animal, creating a site of lifelong, but not germ-
line, production of the gene product, are possible and
practical for livestock applications. This system would
allow designation of an animal for slaughter prior to gene
administration, making any effects of the gene product
on reproductive or other non-growth traits of little con-
cern. Breeding animals and animals chosen as herd re-
placements would remain untreated. Since treatment
would probably involve a single injection, this system
would 1) provide rapid access to the farmer; 2) provide a
good product for the agri-pharmaceutical industry,
which would provide research investment for its devel-
opment; and 3) because of low production costs and
single dose administration, leave the major share of
increased profits for the agricultural producer. Although
this approach is presently at the early research stage, I feel
that it has so many obvious advantages over other alterna-
tives that it should receive major emphasis by our agri-
cultural research community. I can assure you that it has
this emphasis at the Edison Biotechnology Center.
This analysis of the potentially available methods of
effecting the use of a production-enhancing system for
agriculture is a very important exercise because, if this
type of complex analysis is not carried out by the agricul-
tural community and the research, teaching, and exten-
sion arms of agricultural units within our universities,
decisions will be made by other groups. These, at worst,
could create increased loss to the farmer and rancher
through decreased prices for products and increased input
costs. At best, they would leave only a small portion of
the biotechnology profits for the producer. The role of the
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agricultural economist in this aspect of biotechnology is
major. Those involved in technology development look
to him/her for guidance in developing technologies that
are really better for the farmer and rancher and not just
exciting research projects for the researcher and high-
profit products for the agri-pharmaceutical industry.
Although it is not my area of scientific specialization,
it appears that biotechnology will have an impact on
agriculture as large or larger than animal biotechnology.
The best immediate example of its application will
probably be in the development of herbicide-resistant
plants. Already, glyphasate resistant tobacco plants are
being tested by at least two plant biotechnology compa-
nies. The recent development of gene transfer in plants
by clonal cell microinjection promises the rapid devel-
opment of genetically altered, resistant cereal plants
including corn, wheat, and rice. Through the use of
specific resistant plant strains-herbicide pairs, weed
control may soon be reduced to direct spraying. But, like
animal biotechnology, we need to look at the optimal
approaches, best uses, and desired targets for plant bio-
technology from the point of view of the producer and
not the biotechnology company.
In this age of biotechnology, many other factors are
dramatically influencing, perhaps even shaking, the
foundations of agriculture. Our choices for the appli-
cation and use of biotechnology must take these into
account. One of these factors is increased concern by
consumers about the quality, nutritional value, and
healthfulness of the food that they eat. As a member
of the Committee on Technological Options to Improve
Nutritional Attributes of Animal Products of the
National Research Council, I am keenly aware of both
the myth and reality surrounding nutritional and
health deficiencies in the American diet. Whereas
concerns over cholesterol, fats, and excessive calories
are based upon sound data from agencies of the federal
government, the dramatic movement away from specific
products, such as red meat, in response to these con-
cerns is wrong, ill-founded, and potentially nutrition-
ally dangerous. But, since public attitudes often depend
more on myth than truth, the agriculture industry, the
agricultural university community, and especially those
involved with livestock agriculture must act through
information, education, and technology to make the con-
sumer feel comfortable with a reasonable diet including
a substantial proportion of each of the important food
groups. Therefore, in addition to directing the powerful
biotechnology toward increased production traits in ani-
mals and plants, we need to use this technology to im-
prove the composition, healthfulness, and nutritional
value of food products. Animal biotechnology must be
addressed to decreasing the fat and caloric content of
meat. For a variety of nutritional reasons, meat should be
a major part of our diet, but it will remain so only if both
meat composition and attitudes about this product
change. Biotechnology can change meat composition;
this change in composition, and the willingness of the
livestock agriculture sector to work for this change, will
go a long way toward changing attitudes.
Unfortunately, within the present national and world
economy and because of worldwide governmental policies
calling for the lowest prices possible for food, even tech-
nologies that allow farmers and ranchers to approach the
upper limits of production efficiencies will not provide
profit margins anywhere near those in other, more profit-
able, industries. The farmer pays $1,000 to $5,000 for
a computer system that costs $200 to $850 to manu-
facture, and sells corn costing at best $1.75 a bushel to
produce for $2.00 a bushel. The same higher profits are
realized by the equipment manufacturers who supply his
mechanized equipment, the builders who build his facili-
ties, and the suppliers of his agri-chemicals. His profits
from other cereal grains, meat, and all other food prod-
ucts are as low or lower than the corn example. Although
this simplistic analysis of agricultural economics by an
non-economist clearly misses many important factors in-
fluencing the farm economy today, I believe it may rep-
resent the base problem: farmers and ranchers are caught
in a predetermined, low profit margin business. Until
farmers begin to produce high profit margin, non-food
products as part of their overall production, they are
likely to remain economically depressed. An example of
a product that has provided good income on small
acreages in the past is tobacco. Although tobacco is not
likely to remain a major product in the future, it repre-
sents the potential in agriculture for chemical or pharma-
ceutical bio-production, for tobacco is surely a drug. As
only the closest observers of plant biotechnology know,
the largest investors in the plant biotechnology industry
are oil and specialty chemical companies. One of these
companies is Lubrizol, which is a Cleveland-based, spe-
cialty lubricant manufacturer. This firm is heavily com-
mitted to plant biotechnology. Lubrizol appears to be
orchestrating a long-range research and development pro-
gram to produce sophisticated, high value lubricants in
oil-producing plants such as soy bean, sunflower, and
rape. This presents a great opportunity for the farmer. He
may produce a specialty chemical crop destined for Lub-
rizol's processing plant. Of perhaps equal importance is
the fact that such chemical farming may create new eco-
nomic opportunity for non-farming, rural America. It
seems unlikely that any national corporation will wish
to take direct delivery for the unprocessed crop, but
would either establish local pre-processing plants or cre-
ate the opportunity for independent local companies to
serve this function.
Clearly, biotechnology offers far more to agriculture
than improved food-producing systems. Specialty plant
oils are only one of many examples of what is beginning
to be called molecular farming. Any reasonable analysis
shows that microbial fermentation or mammalian cell
culture production of protein or other bio-products is far
less cost efficient than animal or plant production. For
example, a dairy cow may produce close to 1 kg of a
sterile protein, casein, at a cost of approximately $3.00,
whereas microbial fermentation produces the same
amount at a cost of over $500 and in a highly toxic
bacterial medium that requires extensive purification.
Most of our traditional farm species have been selected for
their specific protein or bioproduct production capacity.
Examples include chickens for their egg white ovalbumin
protein and grains for their storage proteins, carbo-
hydrates, and oils. We here today and the presently de-
pressed farm sector have the bioproduction systems of the
future. They are not in the hands of corporations or
biotechnology companies; they are in our hands. We
must work to keep them there and put them to use for
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agriculture and the good of all.
If molecular farming is to become a reality, a large
investment will be required in very basic molecular
biology and the application technologies needed to
bring these production systems to the farm. Genes are
composed of two distinct portions, the information-
containing structural gene and the regulating or or-
chestrating genetic control sequences that direct gene
expression to specific tissues at specific times in concert
with the organism's physiology. By cloning both the
structural genes of products to be produced by molecular
farming and the regulational sequences to direct their
production to dairy cows' mammary secretions, birds'
egg white, or grains' storage proteins, creating gene
chimeras between these elements, and introducing these
gene chimeras into new strains of transgenic animals and
plants, the agricultural research community may provide
the farmers and ranchers of this country with the systems
to produce a fair share of the future high profit margin,
non-food products. The dramatic recent successes of the
biotechnology industry indicate that the technology is
now at a stage where an important agenda for positive
change in agriculture can be established. This change
could greatly aid in the economic development of the
farming community.
In Ohio or Washington, the key issue for the next
decade or more is, and will be, economic development.
Our state and the nation as a whole are in the midst of
an economic conflict. Recently, the senior vice-president
of the Ford Motor Company spoke at Ohio University.
He said: "We are in an economic war with other countries
around the world and our whole way of life depends upon
being one of the winners of this war. Industry and the
private sector look to the minds within America's univer-
sities as allies for much needed help. If you will not
commit your enormous talent to our struggle, we will
look elsewhere and an irrevocable separation between two
of the most important parts of our society will definitely
take place." Economic development is one of those fa-
vored terms of our time. It is a term, moreover, that those
in agricultural research universities must take very seri-
ously during the 1980s and beyond. Although the agri-
cultural components of universities have always had
extensive two-way communication and interaction with
the private agriculture sector through their extension
services, this input usually has not been directed toward
competitive economic development. Rather we have been
either working with slight modifications in the status quo
or involved with specialized research, which, although of
utmost importance in the long run, does not aid the
near-term economic needs of farmers and ranchers. Agri-
culture has supported the universities for several gener-
ations and now, as agriculture is facing the burden of
economic crisis, it needs the special focus and mission-
oriented emphasis of these institutions as never before. I
don't know if my view from Ohio and the Midwest is
darker and more foreboding than the view from other
regions, but the present plight of agriculture here can be
summed up by the words of a popular song by Bruce
Springsteen: "It's like riding a downbound train." Ideas,
abilities, and energy will be needed to bring about the
economic revitalization of agriculture. Biotechnology of-
fers one good mechanism to place the agricultural pro-
ducer back in the mainstream of profitable national and
world enterprise.
Accomplishing the goal of agricultural revitalization
through technological innovation and the resulting de-
velopment of new high tech, non-food products will re-
quire new partnerships and new interactions within the
universities and throughout every sector of our society.
Not only must long-term collaboration be prompted be-
tween the very finest biologists and molecular scientists
in the colleges of arts and sciences and agricultural sci-
entists in the universities, but new partnerships must also
be formed with business and industry. The latter should
include not only the established national or multi-
national corporations, who may have little vested interest
in a region served by the university, but also those still
unstable entrepreneurial start-up companies that will
play a major part in forging the economic new order. No
longer can the university community afford to give away
its ideas to anyone and everyone, because these ideas can
be used to fuel the economy of another region or even
another country. We must learn to direct our ideas and
new production systems to the rightful heirs of this tech-
nology: those who provided us with the means to do our
work. Biotechnology centers in all areas must serve their
regions as those of us at the Edison Biotechnology Center
serve our constituents in Ohio. We must also share fairly
for the betterment and development of all. This sharing
will require new forms of partnership between our insti-
tutions and regions. These partnerships should be based
upon the unique needs and capabilities of each par-
ticipant and upon a sense of equality between par-
ticipants.
This call for biotechnological innovation, agricultural
economic development, and the establishment of new
partnerships comes at a time when the nation is de-
manding excellence in higher education. And what
better time for this challenge! The current passion for
excellence has become a central theme in discussions of
education. The new excellence demanded in higher edu-
cation from many quarters should be more than a dupli-
cation or emulation of pre-existing patterns. Academic
excellence for both state and private regional colleges and
universities during the 1980s and 1990s, especially in
agricultural programs, is not to be as much like Harvard,
Stanford or MIT as possible, but rather to serve as a
partner with government and industry in increasing the
educational and economic opportunities available to their
special constituencies. This excellence is far more ade-
quately understood as a measure of performance than a
repetition of preset patterns. For us at the Edison Animal
Biotechnology Center here in Ohio, how we perform in
integrating the new biotechnology into agriculture, so
that it results in real economic gain for the farmers of
Ohio and the rest of this country, will be our measure of
excellence and their measure of survival.
